Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
Depository Receipt · US41044T1088 (OTC)
Overview
No Price
Closing Price OTC 08.12.2025: 4,00 USD
08.12.2025 21:00
Current Prices from Hangzhou Tigermed Consulting Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
HNGZY
USD
08.12.2025 21:00
4,00 USD
0,00 USD
Company Profile for Hangzhou Tigermed Consulting Co., Ltd. Depository Receipt
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Get up to date insights from finAgent about Hangzhou Tigermed Consulting Co., Ltd.

Company Data

Name Hangzhou Tigermed Consulting Co., Ltd.
Company Hangzhou Tigermed Consulting Co., Ltd.
Website https://www.tigermed.net
Primary Exchange OTC UTC
ISIN US41044T1088
Asset Class Depository Receipt
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Xiaoping Ye D.Phil, EMBA,
Market Capitalization 6 Mrd.
Country China
Currency USD
Employees 10,2 T
Address F18, Building A – Shengda Science Park, 310051 Hangzhou
IPO Date 2022-07-11

Ticker Symbols

Name Symbol
Over The Counter HNGZY
More Shares
Investors who hold Hangzhou Tigermed Consulting Co., Ltd. also have the following shares in their portfolio:
CRSTONE CAP. RES
CRSTONE CAP. RES Share
Shenzhen Noposion Agrochemicals Co.,Ltd
Shenzhen Noposion Agrochemicals Co.,Ltd Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025